We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£74.57
Springer Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
Price data last checked 52 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
About as cheap as it gets. The only time it was cheaper was 2 months ago.
£75 today · all-time low £74 (May 2026) · usually the usual
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 39 days · 39 data points (no recent data)
Price Distribution
Price distribution over 39 days • 2 price levels
Price Analysis
Most common price: £75 (31 days, 79.5%)
Price range: £74 - £75
Price levels: 2 different prices over 39 days
Description
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 3319384562
- Domain
- Amazon UK
- Release Date
- 17 October 2016
- Listed Since
- 07 October 2016
Barcode
No barcode data available
Similar Products You Might Like
Cancer Immunotherapy: Paradigms, Practice and Promise
Springer
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
Springer
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
Springer
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
Springer
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: 9 (Resistance to Targeted Anti-Cancer Therapeutics, 9)
Springer
Molecular Oncology: Underlying Mechanisms and Translational Advancements
Springer
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
Springer
Molecular Targeted Therapy of Lung Cancer
Springer
Immunotherapy for Gastrointestinal Cancer
Springer
Pathobiology of Cancer Regimen-Related Toxicities
Springer
Nutraceuticals and Cancer
Springer
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
Springer
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
Springer
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)
Springer
Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)
Academic Press
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
Springer
Gene-Based Therapies for Cancer (Current Cancer Research)
Springer
Pharmaceutical Perspectives of Cancer Therapeutics
Springer
Genitourinary Cancer 1: 6 (Cancer Treatment and Research, 6)
Springer
Cancer Genetics and Therapeutics: Focus on Phytochemicals
Springer
Targeted Radionuclide Tumor Therapy: Biological Aspects
Springer
Targeted Interference with Signal Transduction Events: 172 (Recent Results in Cancer Research, 172)
Springer